REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
13.04%
↑ 114% above average
Average (39q)
-92.72%
Historical baseline
Range
High:734.62%
Low:-2267.76%
CAGR
-4.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 13.04% |
| Q2 2025 | -1250.00% |
| Q1 2025 | 111.88% |
| Q4 2024 | 13.68% |
| Q3 2024 | -11.43% |
| Q2 2024 | 23.91% |
| Q1 2024 | 3.50% |
| Q4 2023 | -1.42% |
| Q3 2023 | 15.06% |
| Q2 2023 | -3.11% |
| Q1 2023 | -16.67% |
| Q4 2022 | 25.41% |
| Q3 2022 | -17.09% |
| Q2 2022 | 11.73% |
| Q1 2022 | -126.06% |
| Q4 2021 | 601.46% |
| Q3 2021 | -0.74% |
| Q2 2021 | -13.33% |
| Q1 2021 | 3.23% |
| Q4 2020 | -616.67% |
| Q3 2020 | 126.37% |
| Q2 2020 | 15.74% |
| Q1 2020 | -50.00% |
| Q4 2019 | 23.40% |
| Q3 2019 | -2267.76% |
| Q2 2019 | 95.54% |
| Q1 2019 | -841.67% |
| Q4 2018 | 121.43% |
| Q3 2018 | -269.70% |
| Q2 2018 | -90.00% |
| Q1 2018 | 734.62% |
| Q4 2017 | 22.39% |
| Q3 2017 | -42.55% |
| Q2 2017 | 42.68% |
| Q1 2017 | -10.81% |
| Q4 2016 | -7.25% |
| Q3 2016 | -25.45% |
| Q2 2016 | -34.15% |
| Q1 2016 | -105.00% |
| Q4 2015 | 86.84% |